Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia: Results From the Phase 2 ADVANCE Study

PURPOSE/BACKGROUND: Pimavanserin is a selective serotonin 5-HT(2A) receptor inverse agonist/antagonist being investigated in patients with negative symptoms of schizophrenia. This analysis aimed to characterize exposure-response relationships of pimavanserin in this population. METHODS/PROCEDURES: E...

Descripción completa

Detalles Bibliográficos
Autores principales: Darwish, Mona, Bugarski-Kirola, Dragana, Passarell, Julie, Owen, Joel, Jaworowicz, David, DeKarske, Daryl, Stankovic, Srdjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640280/
https://www.ncbi.nlm.nih.gov/pubmed/36190440
http://dx.doi.org/10.1097/JCP.0000000000001611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640280/
https://www.ncbi.nlm.nih.gov/pubmed/36190440
http://dx.doi.org/10.1097/JCP.0000000000001611

Ejemplares similares